Thomas Malley, Director at BeiGene, Ltd. (BGNE), bought 30,000 shares at $32.00 ($960K) on 2016-11-23, disclosed to the SEC on 2016-11-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KURA | BUY | 2015-12-17 | $400K | — | Filing → |
| OVAS | BUY | 2015-04-09 | $143K | — | Filing → |
| OVAS | BUY | 2015-01-15 | $1.8M | — | Filing → |